Stocks · News reference
8-K filing — BioCardia, Inc. (BCDA)
Filed: 2026-08-12 AccNo: 0001437749-26-027332 Size: 284 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Aug 12, 2026, 8:27 PM
- Checked
- Aug 12, 2026, 8:27 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
8-K filing — BioCardia, Inc. (BCDA)
Filed: 2026-08-24 AccNo: 0001437749-26-028778 Size: 178 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgarBioCardia Q2 EPS $(0.13) Beats $(0.18) Estimate
BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.18) by 27.78 percent. This is a 67.5 percent increase over losses of $(0.40) per share from the
Read original at benzingaBioCardia CEO Issued Shareholder Letter To Provide Update; Milestone Includes Submission For Japan's Pharmaceutical and Medical Device Agency Approval Planned For End Of 2026; Driving To Enroll Confirmatory CardiAMP HF II Trial In US
Read original at benzinga